文献速递功能神经外科

三叉神经痛患者从诊断到转诊及外科治疗过程中的性别差异:对公平医疗的启示

Sex differences in patient journeys to diagnosis, referral, and surgical treatment of trigeminal neuralgia: implications for equitable care.
PubMed 文献 · J Neurosurg · 2022-12-30

该横断面研究通过病历回顾随机选取加拿大最大三叉神经痛外科治疗中心的100例经典三叉神经痛患者(女性50例、男性50例),分析性别在诊断、转诊和治疗路径上的差异。结果显示女性转诊时间间隔和总时间间隔均显著长于男性,且转诊时疼痛强度更高,而诊断时间间隔和治疗时间间隔无显著性别差异。作者认为这提示对女性的无意识偏见和歧视,并强调需加快女性三叉神经痛患者的治疗转诊。

要点

  • 女性转诊时间间隔平均53.2个月,显著长于男性的20.4个月(p=0.018)。
  • 女性总时间间隔平均121.1个月,显著长于男性的67.8个月(p=0.018)。
  • 诊断时间间隔和治疗时间间隔无显著性别差异。

核心结论

  • 女性三叉神经痛患者转诊至外科治疗的时间间隔和总时间间隔显著长于男性,且转诊时疼痛强度更高。
  • 研究结果提示存在对女性的无意识偏见和歧视,强调需要加快女性三叉神经痛患者的治疗转诊。

研究设计与样本

  • 通过病历回顾在加拿大最大的三叉神经痛外科治疗中心随机选取经典三叉神经痛患者100例(女性50例、男性50例)进行横断面研究。
  • 使用Python进行Welch t检验、卡方检验、Pearson相关分析和协方差分析等统计检验。

主要发现

  • 女性转诊时间间隔平均53.2个月(中位数27.5个月),男性平均20.4个月(中位数11.0个月),p=0.018。
  • 女性总时间间隔平均121.1个月(中位数78.0个月),男性平均67.8个月(中位数45.2个月),p=0.018。
  • 药物不耐受患者转诊时间间隔平均13.0个月(中位数6.0个月),显著短于药物耐受患者的41.0个月(中位数17.0个月),p<0.001。
  • 药物耐受女性转诊时间间隔平均59.9个月(中位数30.0个月),显著长于药物耐受男性的21.7个月(中位数12.0个月),p=0.017。
  • 诊断时间间隔女性平均63.3个月(中位数24.0个月)vs 男性43.0个月(中位数24.0个月),p=0.263;治疗时间间隔女性平均4.6个月(中位数4.0个月)vs 男性4.7个月(中位数3.0个月),p=0.986,均无统计学显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Trigeminal neuralgia (TN) is an orofacial pain disorder that is more prevalent in females than males. Although an increasing number of studies point to sex differences in chronic pain, how sex impacts TN patients' journeys to care has not been previously addressed. This study sought to investigate sex differences in patients' journeys to diagnosis, referral, and treatment of TN within a large national context. METHODS: Patients with classic TN (n = 100; 50 females and 50 males) were randomly selected through chart reviews at the largest surgical treatment center for TN in Canada for a cross-sectional study. Statistical tests, including Welch's t-test, the chi-square test, Pearson's correlations, and analyses of covariance, were conducted with Python. RESULTS: Key discrepancies between sexes in access to care were identified. Females had a significantly longer referral time interval (average 53.2 months vs 20.4 months, median 27.5 months vs 11.0 months, p = 0.018) and total time interval (average 121.1 months vs 67.8 months, median 78.0 months vs 45.2 months, p = 0.018) than males, despite reporting higher pain intensity at referral. Although medically intolerant patients had a significantly shorter referral time interval than medically tolerant patients (average 13.0 months vs 41.0 months, median 6.0 months vs 17.0 months, p < 0.001), medically tolerant females had a significantly longer referral time interval than medically tolerant males (average 59.9 months vs 21.7 months, median 30.0 months vs 12.0 months, p = 0.017). No statistically significant differences were detected between the sexes for diagnostic time interval (average 63.3 months vs 43.0 months, median 24.0 months vs 24.0 months, p = 0.263) or treatment time interval (average 4.6 months vs 4.7 months, median 4.0 months vs 3.0 months, p = 0.986). CONCLUSIONS: Critical sex differences in patients' journeys to TN surgical treatment were identified, with females enduring considerably longer referral timelines and expressing significantly greater pain intensity than males at referral. Taken together, our findings suggest the presence of unconscious bias and discrimination against females and highlight the need for expediting TN treatment referral for female TN patients.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hung PS, Byeon AG, Noorani A, et al. Sex differences in patient journeys to diagnosis, referral, and surgical treatment of trigeminal neuralgia: implications for equitable care. J Neurosurg. 2022. PMID: 36585864. doi:10.3171/2022.11.JNS221191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。